NCT03137641
- Conditions
- Antineoplastic Drugs Contamination Prevalence
- Locations
-
- Hôpital Pellegrin Bordeaux, France
- CHU de Toulouse Toulouse, France
- IUCT-Oncopole Toulouse, France
Clinical trial condition
Explore clinical trials studying Antineoplastic Drugs Contamination Prevalence. Study availability and eligibility vary by location and protocol.
NCT03137641